Search Results - "di Paola, Eugenio Donato"
-
1
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study
Published in PloS one (03-11-2020)“…Psoriasis is an inflammatory and chronic skin disorder associated with physical and psychological burden impairing patients' quality of life. In the last…”
Get full text
Journal Article -
2
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy
Published in Current medical research and opinion (01-09-2020)“…Inflammatory bowel diseases (IBDs) are a public health issue with over 3.5 million patients in Europe, but the advent of several biologic agents has completely…”
Get full text
Journal Article -
3
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity
Published in Neuropharmacology (01-01-2013)“…Aripiprazole (APZ) is regarded as a first-line atypical antipsychotic used for the treatment of first and multiple episodes of schizophrenia to improve…”
Get full text
Journal Article -
4
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes
Published in Molecules (Basel, Switzerland) (21-09-2016)“…The usage of dietary supplements and other natural products to treat neurological diseases has been growing over time, and accumulating evidence suggests that…”
Get full text
Journal Article -
5
Novel 3-Carboxy- and 3-Phosphonopyrazoline Amino Acids as Potent and Selective NMDA Receptor Antagonists: Design, Synthesis, and Pharmacological Characterization
Published in ChemMedChem (03-09-2010)“…The design and synthesis of new N1‐substituted 3‐carboxy‐ and 3‐phosphonopyrazoline and pyrazole amino acids that target the glutamate binding site of NMDA…”
Get full text
Journal Article -
6
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
Published in The Lancet (British edition) (27-10-2001)“…Gastrointestinal stromal tumours (GISTs) are rare tumours of the gastrointestinal tract characterised by cell-surface expression of the tyrosine kinase KIT…”
Get full text
Journal Article -
7
The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment
Published in CNS & neurological disorders drug targets (01-01-2017)“…It is currently known that erythrocytes are the major source of sphingosine 1-phosphate (S1P) in the body. S1P acts both extracellularly as a cellular mediator…”
Get more information
Journal Article -
8
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials
Published in Pharmacological research (01-03-2018)“…[Display omitted] Dipeptidyl-peptidase-4 (DPP-4) inhibitors are a relatively new class of non-insulin glucose-lowering agents, belonging to the incretin…”
Get full text
Journal Article -
9
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study
Published in Journal of hematology and oncology (26-06-2023)“…We developed a 13-mer locked nucleic acid (LNA) inhibitor of miR-221 (LNA-i-miR-221) with a full phosphorothioate (PS)-modified backbone. This agent…”
Get full text
Journal Article -
10
Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: A new treatment for metastatic soft tissue sarcoma
Published in Critical reviews in oncology/hematology (01-02-2014)“…Abstract Soft tissue sarcomas (STS) are rare tumors with mesenchymal origin, accounting for 1% of all human cancer. Local control of STS can be obtained…”
Get full text
Journal Article -
11
Pharmacodynamic potentiation of antiepileptic drugs’ effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice
Published in Pharmacological research (01-04-2013)“…It is known that the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are effective in both the primary and the secondary…”
Get full text
Journal Article -
12
Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats
Published in Epilepsy research (01-10-2018)“…•Perampanel is efficacious against audiogenic seizures in GEPR-9 s rats.•Perampanel effects are maintained over 10 weeks of treatment.•Perampanel…”
Get full text
Journal Article -
13
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice
Published in Pharmacology, biochemistry and behavior (01-04-2004)“…In the present study, the susceptibility of knockout interleukin-6 (IL-6 −/−) mice to various convulsant stimuli has been evaluated and compared with other…”
Get full text
Journal Article -
14
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice
Published in Pharmacological research (01-03-2012)“…The renin–angiotensin system (RAS) exists in the brain and it may be involved in pathogenesis of neurological and psychiatric disorders including seizures. The…”
Get full text
Journal Article -
15
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group
Published in Cancer chemotherapy and pharmacology (01-04-2005)“…Imatinib pharmacokinetics (PK) may be affected by a number of factors that are related to the disease being treated and to the response of that disease to…”
Get full text
Journal Article -
16
Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
Published in European journal of cancer (1990) (01-09-2002)“…In a phase I study conducted by the EORTC Soft Tissue and Bone Sarcoma Group, 40 patients with advanced soft tissue sarcomas, most of whom had gastrointestinal…”
Get full text
Journal Article -
17
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice
Published in Neuroscience research (01-09-2004)“…In the present study, the susceptibility of the mdx mouse, a dystrophin-deficient genetic model of Duchenne muscular dystrophy (DMD), to various convulsant…”
Get full text
Journal Article -
18
Pharmacovigilance in pharmaceutical companies: An overview
Published in Journal of pharmacology & pharmacotherapeutics (01-12-2013)“…Pharmacovigilance is responsible for monitoring the safety of medicines in normal clinical use and during clinical trials. In the light of the experience…”
Get full text
Journal Article -
19
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy
Published in Epilepsy & behavior (01-08-2008)“…Abstract N -Acetyl-1-(4-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (THIQ-10c) is a noncompetitive…”
Get full text
Journal Article -
20
Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice
Published in Epilepsy research (01-07-2007)“…Summary Levetiracetam (LEV, [S]-alpha-ethyl-2-oxo-1-pyrrolidine acetamide) is a new antiepileptic that has been used as adjunctive therapy to treat patients…”
Get full text
Journal Article